Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 7;10(3):324-328.
doi: 10.1021/acsmedchemlett.8b00590. eCollection 2019 Mar 14.

Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists

Affiliations

Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists

Aniket Magarkar et al. ACS Med Chem Lett. .

Abstract

The target residence time (RT) for a given ligand is one of the important parameters that have to be optimized during drug design. It is well established that shielding the receptor-ligand hydrogen bond (H-bond) interactions from water has been one of the factors in increasing ligand RT. Building on this foundation, here we report that shielding an intra-protein H-bond, which confers rigidity to the binding pocket and which is not directly involved in drug-receptor interactions, can strongly influence RT for CCR2 antagonists. Based on our recently solved CCR2 structure with MK-0812 and molecular dynamics (MD) simulations, we show that the RT for this and structurally related ligands is directly dependent on the shielding of the Tyr120-Glu291 H-bond from the water. If solvated this H-bond is often broken, making the binding pocket flexible and leading to shorter RT.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
(A) Thermodynamic and kinetic parameters of MK-0812, 8, and 15a (Vilums et al.,) as well as a simplified energy barrier defining the free energy differences of the ligand bound state ΔGBS as well as the free energy differences of the transition state ΔGTS. (B) Structures of the molecules under investigation (X = N for MK-0812 and X = C for 8 and 15a) as well as quantification of the free energy differences in comparison to MK-0812.
Figure 2
Figure 2
(A) Overlay of ligands (simulation snapshot). MK-0812 (in red), 15a (in yellow), and 8 (in blue) in CCR2 binding pocket. (B) Overlay of water density mesh of MK-0812 (red) and 15a (yellow); the “extra-water” density region for MK-0812 is shown in the green circle. (C) Overlay of water density mesh of MK-0812 (red) and 8 (blue); the “extra-water” density is shown in the green circle. (D) Water network in the protein binding site for MK-0812 and (E) for 15a.
Figure 3
Figure 3
H-bond interactions in the CCR2 binding pocket. (A) Schematic showing broken H-bond between Glu291-Tyr120 due to insertion of water molecules in between for MK-0812. Water molecule highlighted by the green circle denotes the extra water density region identified for MK-0812. (B) H-bond between Glu291-Tyr120 vs time for MK-0812, 15a, and 8.
Figure 4
Figure 4
Tyr120-Glu291 interactions: (A) Schematic representation of Glu291 and Tyr120 heavy atoms showing conformational space explored by these residues from 1 μs long MD simulations. (B) RMSF showing the flexibility of heavy atoms of Glu291 and Ty120 for MK-0812, 15a, and 8.

Similar articles

Cited by

References

    1. Zlotnik A.; Yoshie O. The Chemokine Superfamily Revisited. Immunity 2012, 36 (5), 705–716. 10.1016/j.immuni.2012.05.008. - DOI - PMC - PubMed
    1. Kurihara T.; Warr G.; Loy J.; Bravo R. Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor. J. Exp. Med. 1997, 186 (10), 1757–1762. 10.1084/jem.186.10.1757. - DOI - PMC - PubMed
    1. Vestergaard C.; Just H.; Baumgartner Nielsen J.; Thestrup-Pedersen K.; Deleuran M. Expression of CCR2 on Monocytes and Macrophages in Chronically Inflamed Skin in Atopic Dermatitis and Psoriasis. Acta Derm. Venereol. 2004, 84 (5), 353–358. 10.1080/00015550410034444. - DOI - PubMed
    1. Katschke K. J.; Rottman J. B.; Ruth J. H.; Qin S.; Wu L.; LaRosa G.; Ponath P.; Park C. C.; Pope R. M.; Koch A. E. Differential Expression of Chemokine Receptors on Peripheral Blood, Synovial Fluid, and Synovial Tissue Monocytes/Macrophages in Rheumatoid Arthritis. Arthritis Rheum. 2001, 44 (5), 1022–1032. 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N. - DOI - PubMed
    1. Boring L.; Gosling J.; Cleary M.; Charo I. F. Decreased Lesion Formation in CCR2–/– Mice Reveals a Role for Chemokines in the Initiation of Atherosclerosis. Nature 1998, 394 (6696), 894–897. 10.1038/29788. - DOI - PubMed